Increased arterial stiffness in HIV-infected children: Risk factors and antiretroviral therapy

Antiviral Therapy

Volumn 14, Issue 8, 2009, Pages 1075-1079

  Charakida, Marietta ^a   Loukogeorgakis, Stavros P ^a   Okorie, Michael I ^a   Masi, Stefano ^a   Halcox, Julian P ^a   Deanfield, John E ^a   Klein, Nigel J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ADOLESCENT; ARTICLE; CAROTID ARTERY; CHILD; ELASTICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PULSATILE FLOW; RADIAL ARTERY; RISK FACTOR;

ADOLESCENT; ANTI-HIV AGENTS; CAROTID ARTERIES; CHILD; ELASTICITY; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; PULSATILE FLOW; RADIAL ARTERY; RISK FACTORS;

EID: 77949316647     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1437     Document Type: Article

References (20)

1. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349:1993-2003.
2. Jiang B, Hebert VY, Zavecz JH, Dugas TR. Antiretrovirals induce direct endothelial dysfunction in vivo. J Acquir Immune Defic Syndr 2006; 42:391-395. (Pubitemid 44050884)
3. Hurlimann D, Weber R, Enseleit F, Luscher TF. HIV infection, antiretroviral therapy, and endothelium. Herz 2005; 30:472-480. German. (Pubitemid 41367138)
4. Charakida M, Donald AE, Green H, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005; 112:103-109. (Pubitemid 40962575)
5. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004; 18:1037-1041. (Pubitemid 38591195)
6. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664-670.
7. Altunkan S, Oztas K, Seref B. Arterial stiffness index as a screening test for cardiovascular risk: a comparative study between coronary artery calcification determined by electron beam tomography and arterial stiffness index determined by a VitalVision device in asymptomatic subjects. Eur J Intern Med 2005; 16:580-584. (Pubitemid 41728213)
8. Asmar R, Darne B, el Assaad M, Topouchian J. Assessment of outcomes other than systolic and diastolic blood pressure: pulse pressure, arterial stiffness and heart rate. Blood Press Monit 2001; 6:329-333. (Pubitemid 34194889)
9. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241. (Pubitemid 34163575)
10. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in endstage renal disease. Circulation 1999; 99:2434-2439. (Pubitemid 29218240)
11. O'Rourke MF. Wave travel and reflection in the arterial system. J Hypertens Suppl 1999; 17:S45-S47.
12. Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002; 53:189-192. (Pubitemid 34264274)
13. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73:17-24.
14. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep 1994; 43:1-10.
15. Sevastianova K, Sutinen J, Westerbacka J, Ristola M, Yki-Jarvinen H. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy. Antivir Ther 2005; 10:925-935. (Pubitemid 43076344)
16. Schillaci G, De Socio GV, Pirro M, et al. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol 2005; 25:2381-2385. (Pubitemid 41552658)
17. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
18. Schillaci G, De Socio GV, Pucci G, et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 2008; 52:308-313.
19. van Wijk JP, de Koning EJ, Cabezas MC, et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol 2006; 47:1117-1123.
20. van Vonderen MG, Smulders YM, Stehouwer CD, et al. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr 2009; 50:153-161.